FDA clears IVD assay to assess complete response in multiple myeloma

The US FDA has granted 510(k) clearance for the Hydrashift 2/4 daratumumab assay from Sebia, which is intended for use with Hydragel IF for the qualitative detection of monoclonal proteins in human serum by immunofixation electrophoresis. Read more

25 Jan 2018 16:45 Technology